Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Your client has multiple sclerosis: understanding the challenge.
Perception of muscular effort in multiple sclerosis.
New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage.
Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI.
Ultrasonographic diagnosis of demyelinating neuropathy.
Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: Beneficial effects in experimental autoimmune encephalomyelitis.
[Multiple sclerosis].
Multiple sclerosis.
Impaired early B cell tolerance in patients with rheumatoid arthritis.
Toxicological aspects of injectable gold-hyaluronan combination as a treatment for neuroinflammation.
Involvement of aquaporin 4 in astrocyte function and neuropsychiatric disorders.
The case for measuring anti-drug antibodies in people with multiple sclerosis.
Soluble CD163 as a Marker of Macrophage Activity in Newly Diagnosed Patients with Multiple Sclerosis.
Endometriosis and susceptibility to multiple sclerosis: is there any absolute truth?
[Driving ability with multiple sclerosis.]
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Sedentary behavior is associated with disability status and walking performance, but not cognitive function, in multiple sclerosis.
A cytoarchitecture-driven myelin model reveals area-specific signatures in human primary and secondary areas using ultra-high resolution in-vivo brain MRI.
Gait termination in individuals with multiple sclerosis.
Altered resting-state functional connectivity in cognitively preserved pediatric-onset MS patients and relationship to structural damage and cognitive performance.
Brugada sign in a multiple sclerosis patient: Relation to autonomic nervous system dysfunction and therapeutic dilemmas.
miR-27a and miR-214 exert opposite regulatory roles in Th17 differentiation via mediating different signaling pathways in peripheral blood CD4(+) T lymphocytes of patients with relapsing-remitting multiple sclerosis.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
JC virus seroprevalence and seroconversion in multiple sclerosis cohort: A Middle-Eastern study.
Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.
Pages
« first
‹ previous
…
491
492
493
494
495
496
497
498
499
…
next ›
last »